Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jan;10(1):1-3.
doi: 10.4168/aair.2018.10.1.1.

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis

Affiliations
Editorial

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis

Myung Hyun Sohn. Allergy Asthma Immunol Res. 2018 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no financial or other issues that might lead to conflict of interest.

References

    1. Solé D, Rosário Filho NA, Sarinho ES, Camelo-Nunes IC, Barreto BA, Medeiros ML, et al. Prevalence of asthma and allergic diseases in adolescents: nine-year follow-up study (2003–2012) J Pediatr (Rio J) 2015;91:30–35. - PubMed
    1. Kim DH, Han K, Kim SW. Relationship between allergic rhinitis and mental health in the general Korean adult population. Allergy Asthma Immunol Res. 2016;8:49–54. - PMC - PubMed
    1. Ozdoganoglu T, Songu M. The burden of allergic rhinitis and asthma. Ther Adv Respir Dis. 2012;6:11–23. - PubMed
    1. Ciprandi G, Caimmi D, Miraglia Del Giudice M, La Rosa M, Salpietro C, Marseglia GL. Recent developments in United airways disease. Allergy Asthma Immunol Res. 2012;4:171–177. - PMC - PubMed
    1. Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2017 Forthcoming. - PubMed

Publication types